Cargando…

Prevalence and Therapeutic Challenges of Fungal Drug Resistance: Role for Plants in Drug Discovery

Antimicrobial resistance is a global issue that threatens the effective practice of modern medicine and global health. The emergence of multidrug-resistant (MDR) fungal strains of Candida auris and azole-resistant Aspergillus fumigatus were highlighted in the Centers for Disease Control and Preventi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marquez, Lewis, Quave, Cassandra L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235788/ https://www.ncbi.nlm.nih.gov/pubmed/32244276 http://dx.doi.org/10.3390/antibiotics9040150

Ejemplares similares

Drug Resistance and Evolvability in an Emerging Human Fungal Pathogen
por: Billmyre, R. Blake
Publicado: (2022)

Potent Antifungal Activity of Penta-O-galloyl-β-d-Glucose against Drug-Resistant Candida albicans, Candida auris, and Other Non-albicans Candida Species
por: Marquez, Lewis, et al.
Publicado: (2023)

Drug-resistant tuberculosis: is India ready for the challenge?
por: Chatterjee, Soumya, et al.
Publicado: (2018)

Screen “play” for drug discovery
por: Narla, Anupama, et al.
Publicado: (2022)

Pathways to new drug discovery in neuropsychiatry
por: Berk, Michael
Publicado: (2012)

Plant/Bacterial Virus-Based Drug Discovery, Drug Delivery, and Therapeutics
por: Sokullu, Esen, et al.
Publicado: (2019)

Antiviral Drug Discovery To Address the COVID-19 Pandemic
por: Richman, Douglas D.
Publicado: (2020)

Therapeutic Potential of Plants as Anti-microbials for Drug Discovery
por: Perumal Samy, Ramar, et al.
Publicado: (2010)

Molecular characterization of neuroprotective activities of plant based products could revive their utilization and lead discovery of new drug candidates for brain diseases
por: Hegde, Muralidhar L.
Publicado: (2014)

On drug discovery against infectious diseases and academic medicinal chemistry contributions
por: Janin, Yves L
Publicado: (2022)

Ex-chitin-g news on drug-induced fungal epitope unmasking
por: Wheeler, Robert T.
Publicado: (2023)

Artificial intelligence in interdisciplinary life science and drug discovery research
por: Bajorath, Jürgen
Publicado: (2022)

Structure‐based drug discovery facilitates future painkiller development
por: Li, Yuqing, et al.
Publicado: (2022)

Question of the Animal-Plant-Fungal Divergence
por: Matsutani, Sachiko
Publicado: (2004)

Quantifying synergy in the bioassay-guided fractionation of natural product extracts
por: Dettweiler, Micah, et al.
Publicado: (2020)

Therapeutic drug monitoring: linezolid too?
por: Richards, Guy A, et al.
Publicado: (2014)

Molecular dynamics simulations: from structure function relationships to drug discovery
por: Nair, Pramod C, et al.
Publicado: (2014)

The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance
por: Vandenbroucke-Grauls, Christina M J E, et al.
Publicado: (2019)

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs
por: Layton, Jodi L., et al.
Publicado: (2018)

The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies
por: Blanco-González, Alexandre, et al.
Publicado: (2023)

A diverse global fungal library for drug discovery
por: Niu, Guodong, et al.
Publicado: (2020)

Safety concerns on the development of novel therapeutic drugs
por: Ospelt, Caroline, et al.
Publicado: (2006)

Inositol Polyphosphate Kinases, Fungal Virulence and Drug Discovery
por: Li, Cecilia, et al.
Publicado: (2016)

Fungal Endophytes as Efficient Sources of Plant-Derived Bioactive Compounds and Their Prospective Applications in Natural Product Drug Discovery: Insights, Avenues, and Challenges
por: Singh, Archana, et al.
Publicado: (2021)

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs
por: Balogh, Erin P., et al.
Publicado: (2019)

Shifting North American drug markets and challenges for the system of care
por: Krausz, R. Michael, et al.
Publicado: (2021)

Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis
por: Srivastava, Shashikant
Publicado: (2015)

Key Milestones in HCV Discovery and Therapeutics
por: Cheng, Xiaoming, et al.
Publicado: (2020)

Fungal Drug Discovery for Chronic Disease: History, New Discoveries and New Approaches
por: Prescott, Thomas A. K., et al.
Publicado: (2023)

Choreographing atomic motions of macromolecular machines in action: Towards dynamics‐based drug discovery
por: Zou, Shitao, et al.
Publicado: (2022)

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges
por: Lee, Emma R., et al.
Publicado: (2020)

Fungal Biofilms and Drug Resistance
por: Jabra-Rizk, Mary Ann, et al.
Publicado: (2004)

The Power of the Web in Cancer Drug Discovery and Clinical Trial Design: Research without a Laboratory?
por: Galustian, Christine, et al.
Publicado: (2010)

Challenges in Drug Discovery for Intracellular Bacteria
por: Tucker, Allison N., et al.
Publicado: (2021)

Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
por: Villaverde, Antonio, et al.
Publicado: (2012)

In vitro tests for drug resistance in Plasmodium falciparum
por: Wernsdorfer, Walther H.
Publicado: (2012)

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
por: Taube, Sheila E., et al.
Publicado: (2009)

Drug supply shortage in Nigeria during COVID-19: efforts and challenges
por: Faiva, Edward, et al.
Publicado: (2021)

Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
por: Machado, Diana, et al.
Publicado: (2018)

Drug repositioning: Progress and challenges in drug discovery for various diseases
por: Hua, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_duicjgsmcu0m2g3qc0jjdskqrs